Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-09-20 00:00:00 ET · period of report 2021-09-16 · accession 0001209191-21-056956 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-20 | 2021-09-16 | TXG | STUELPNAGEL JOHN R | Dir | S - Sale | $156.33 | -5,000 | 374.4K | -1% | -$781.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-09-16 | S | D | 700 | $154.45 | 375,916 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $154.085 to $154.97. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-09-16 | S | D | 1,169 | $157.75 | 371,616 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $157.26 to $158.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-09-16 | S | D | 1,631 | $156.72 | 372,785 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $156.25 to $157.24. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-09-16 | S | D | 1,500 | $155.69 | 374,416 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $155.19 to $156.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |